EP1796643 - TREATMENT OF ANDROGEN - DEPRIVATION INDUCED OSTEOPOROSIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.09.2012 Database last updated on 02.11.2024 | Most recent event Tooltip | 07.09.2012 | Application deemed to be withdrawn | published on 10.10.2012 [2012/41] | Applicant(s) | For all designated states GTX, Inc. 3 North Dunlap, 3rd Floor, Van Vleet Building Memphis, TN 38163 / US | [N/P] |
Former [2007/25] | For all designated states GTX Inc. 3 North Dunlap, 3rd Floor, Van Vleet Building Memphis, TN 38163 / US | Inventor(s) | 01 /
STEINER, Mitchell, S. 2600 Forest-Hill Irene Road Germantown, TN 38139 / US | 02 /
VEVERKA, Karen, A. 669 Featherwind Cove S. Cordova, TN 38018 / US | 03 /
RAGHOW, Sharan 1647 Courts Meadow Cove Collierville, TN 38017 / US | [2007/40] |
Former [2007/25] | 01 /
STEINER, Mitchell, S. 8894 Silver Bark Drive Germantown, TN 38138 / US | ||
02 /
VEVERKA, Karen, A. 669 Featherwind Cove S. Cordova, TN 38018 / US | |||
03 /
RAGHOW, Sharan 1647 Courts Meadow Cove Collierville, TN 38017 / US | Representative(s) | Lord, Hilton David, et al Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | [N/P] |
Former [2010/28] | Lord, Hilton David, et al Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | ||
Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
Former [2007/25] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 05797480.0 | 19.09.2005 | [2007/25] | WO2005US32998 | Priority number, date | US20040944465 | 20.09.2004 Original published format: US 944465 | [2007/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006033979 | Date: | 30.03.2006 | Language: | EN | [2006/13] | Type: | A1 Application with search report | No.: | EP1796643 | Date: | 20.06.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.03.2006 takes the place of the publication of the European patent application. | [2007/25] | Search report(s) | International search report - published on: | US | 30.03.2006 | (Supplementary) European search report - dispatched on: | EP | 12.08.2009 | Classification | IPC: | A61K9/14, A61K31/138, A61P5/32, A61P13/08, A61P35/00 | [2009/37] | CPC: |
A61K31/135 (EP,US);
A61K9/14 (KR);
A61K31/138 (EP,KR,US);
A61K9/0014 (EP,US);
A61K9/0019 (EP,US);
A61K9/0021 (EP,US);
A61K9/0024 (EP,US);
A61K9/0053 (EP,US);
A61P13/08 (EP);
A61P15/12 (EP);
A61P19/10 (EP);
A61P29/00 (EP);
|
Former IPC [2007/25] | A61K9/14 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/25] | Extension states | AL | 17.04.2007 | BA | 17.04.2007 | HR | 17.04.2007 | MK | 17.04.2007 | YU | 17.04.2007 | Title | German: | BEHANDLUNG VON OSTEOPOROSE DURCH ANDROGEN-MANGEL | [2007/25] | English: | TREATMENT OF ANDROGEN - DEPRIVATION INDUCED OSTEOPOROSIS | [2007/25] | French: | TRAITEMENT DE L'OSTEOPOROSE INDUITE PAR UNE CARENCE EN ANDROGENE | [2007/25] | Entry into regional phase | 17.04.2007 | National basic fee paid | 17.04.2007 | Search fee paid | 17.04.2007 | Designation fee(s) paid | 17.04.2007 | Examination fee paid | Examination procedure | 20.07.2006 | Request for preliminary examination filed International Preliminary Examining Authority: US | 17.04.2007 | Examination requested [2007/25] | 05.06.2007 | Amendment by applicant (claims and/or description) | 30.11.2009 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2010 | Reply to a communication from the examining division | 03.04.2012 | Application deemed to be withdrawn, date of legal effect [2012/41] | 08.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/41] | Divisional application(s) | EP08153021.4 / EP1935415 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.11.2009 | Fees paid | Renewal fee | 27.09.2007 | Renewal fee patent year 03 | 15.09.2008 | Renewal fee patent year 04 | 11.09.2009 | Renewal fee patent year 05 | 14.09.2010 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0189515 (ASTRAZENECA AB [SE], et al) [A] 1-9 * pages 6,8 *; | [A]WO03047504 (GTX INC [US], et al) [A] 1-9 * paragraph [0025]; claim - *; | [A]WO2004016272 (UPJOHN CO [US], et al) [A] 1-9 * claims 1,10,13 *; | [PX]EP1574212 (GTX INC [US]) [PX] 1-9 * claim 3 *; | [E]WO2006010162 (GTX INC [US], et al) [E] 1-9 * paragraphs [0010] , [0041] , [0043]; example -; claims 50,51 *; | [E]EP1862165 (GTX INC [US]) [E] 1-9* claim - *; | [A] - CHEN A C ET AL, "Complications of androgen deprivation therapy in men with prostate cancer", CURRENT ONCOLOGY REPORTS 200405 GB, (200405), vol. 6, no. 3, ISSN 1523-3790, pages 209 - 215, XP009120999 [A] 1-9 * page 210, column L * DOI: http://dx.doi.org/10.1007/s11912-004-0051-0 | International search | [X]US2004142973 (CASTLE ERIK P [US]) |